AbbVie, AndroGel partner owe $448 million in antitrust case: U.S. judge

(Reuters) - A U.S. judge on Friday found that pharmaceutical company AbbVie Inc used sham litigation to illegally prevent generic versions of testosterone replacement drug AndroGel from getting to market and ordered the drugmaker and its partner to pay $448 million.


from Reuters: Health News https://ift.tt/2Kjg2VU

Comentarii

Postări populare de pe acest blog

12 Sparkling Wine Cocktails for the Holidays

Take Your Fourth of July Barbecue Into the Future with These New Products